Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cardiovascular Agents × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1 Cardiovascular Diseases 1

Interventions

Cisplatin 467 Radiotherapy 338 Cyclophosphamide 324 Carboplatin 323 Paclitaxel 304 Capecitabine 303 Oxaliplatin 294 Docetaxel 281 Gemcitabine 278 Fluorouracil 255 apatinib 231 Drug Therapy 230 Bevacizumab 215 camrelizumab 192 Etoposide 179 Irinotecan 165 Doxorubicin 159 Dexamethasone 138 Leucovorin 137 Blood Specimen Collection 132 Cytarabine 131 pembrolizumab 125 Neoadjuvant Therapy 125 sintilimab 120 anlotinib 119 Pemetrexed 119 toripalimab 115 Rituximab 113 S 1 (combination) 112 Surgical Procedures, Operative 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05216913 2023-05-16

OPTIMUS

University of Manchester

Cardiovascular Diseases, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡